Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$6.18
-5.2%
$6.65
$6.02
$14.38
$507.65M0.84383,242 shs526,076 shs
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.61
-12.5%
$2.91
$1.59
$9.37
$74.07M0.43649,469 shs1.87 million shs
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$34.46
-3.9%
$38.02
$21.77
$81.56
$494.31M1.34711,868 shs858,455 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.76
-0.2%
$11.07
$8.15
$19.44
$523.25M2.191.15 million shs514,225 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
-5.21%-5.94%-9.78%-15.80%-11.84%
Pulmonx Corporation stock logo
LUNG
Pulmonx
-12.50%-51.80%-40.81%-57.29%-76.70%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-3.88%-9.51%-12.85%-4.70%+3.95%
ZimVie Inc. stock logo
ZIMV
ZimVie
-0.16%+0.21%+87.41%+100.43%-11.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bioventus Inc. stock logo
BVS
Bioventus
3.145 of 5 stars
3.40.00.00.02.63.31.3
Pulmonx Corporation stock logo
LUNG
Pulmonx
3.862 of 5 stars
4.33.00.00.02.33.31.3
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
2.5495 of 5 stars
3.63.00.00.02.91.70.0
ZimVie Inc. stock logo
ZIMV
ZimVie
0.859 of 5 stars
1.05.00.00.01.91.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
2.75
Moderate Buy$13.75122.49% Upside
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.56
Moderate Buy$7.66376.04% Upside
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
3.25
Buy$82.00137.96% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$17.75-5.38% Downside

Current Analyst Ratings Breakdown

Latest LUNG, BVS, SMLR, and ZIMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/1/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $5.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $16.00
7/31/2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$9.00 ➝ $2.50
7/31/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/28/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$61.00
7/22/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$9.00 ➝ $19.00
7/9/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$95.00
7/8/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$101.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$567.70M0.89$0.49 per share12.58$2.80 per share2.21
Pulmonx Corporation stock logo
LUNG
Pulmonx
$83.79M0.77N/AN/A$2.17 per share0.74
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$56.29M8.44$4.30 per share8.01$24.90 per share1.38
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.16$1.85 per share10.12$14.82 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
-$156.23M-$0.48N/A13.43N/A-7.11%15.61%4.01%N/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$56.39M-$1.43N/AN/AN/A-62.88%-66.36%-35.51%N/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$40.90M-$2.61N/AN/A-60.69%19.75%15.47%8/4/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/A-4.39%6.37%3.34%8/7/2025 (Estimated)

Latest LUNG, BVS, SMLR, and ZIMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
8/4/2025Q2 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-$0.27N/AN/AN/A$8.10 millionN/A
7/30/2025Q2 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.40-$0.38+$0.02-$0.38$23.46 million$23.86 million
7/30/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
N/A$0.26N/A-$0.14$112.60 million$116.66 million
5/13/2025Q1 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
N/A-$0.76N/A-$6.74N/A$8.84 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/7/2025Q1 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.37-$0.36+$0.01-$0.36$22.03 million$22.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
1.85
1.41
0.99
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.38
4.97
4.29
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
0.59
0.52
0.51
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
49.37%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
33.00%
Pulmonx Corporation stock logo
LUNG
Pulmonx
6.80%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
16.40%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20082.14 million54.46 millionNot Optionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25040.26 million37.52 millionOptionable
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
12013.79 million11.53 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable

Recent News About These Companies

ZimVie (NASDAQ:ZIMV) Downgraded by B. Riley to "Neutral"
ZimVie (NASDAQ:ZIMV) Releases Quarterly Earnings Results
ZimVie (ZIMV) Projected to Post Earnings on Thursday
ZimVie Reports Second Quarter 2025 Financial Results
Insights into ZimVie's Upcoming Earnings
ZimVie to sell to investment firm for about $730M
BC-Most Active Stocks
...
ZimVie Inc to be Acquired by ARCHIMED

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bioventus stock logo

Bioventus NYSE:BVS

$6.18 -0.34 (-5.21%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$6.18 0.00 (0.00%)
As of 08/1/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$1.61 -0.23 (-12.50%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.67 +0.06 (+3.66%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$34.46 -1.39 (-3.88%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$34.67 +0.21 (+0.62%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$18.76 -0.03 (-0.16%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$18.76 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.